KEQUKEWAUNEE SCIENTIFIC CORP /DE/(KEQU)Stock Analysis

AI analysis on 2,800+ stocks →
TechnologyNasdaq
Institutional-grade research for retail investors
SEC EDGAR: CIK 55529KEQU stock profile & AI dashboard →

13F Pro Quality Score

51.4/100

Rank #1,392 of 2,879 stocksTOP 50%

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

83.6/100

Profitability

37.8/100

Balance Sheet

66.2/100

Earnings Quality

22.7/100

Free Cash Flow

42.7/100

Institutional Flow

42.8/100

Revenue Scale

28.4/100

Dilution Risk

64.9/100

KEQU Stock Analysis & AI Quality Score

AI stock analysis and institutional research for KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU), a Technology sector company. 13F Pro's AI-powered ranking engine scores KEQU at 51.4/100 on a 32-signal composite quality model, placing it at rank #1,392 of 2,879 stocks — the top half of the AI-ranked universe. KEQU scores in the top quartile across revenue growth (83.6). Areas of concern include earnings quality (22.7) and revenue scale (28.4), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q4 2026), KEWAUNEE SCIENTIFIC CORP /DE/ reports quarterly revenue of $71.4M, net income of $3.4M, an operating margin of 7.3%. Top institutional holders of KEQU by reported 13-F value include NORTHERN, DIMENSIONAL FUND ADVISORS, Minerva Advisors, based on the most recent SEC filings. KEQU trades on the Nasdaq exchange and files with the SEC under CIK 55529. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate KEQU daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for KEWAUNEE SCIENTIFIC CORP /DE/ directly from SEC EDGAR. KEWAUNEE SCIENTIFIC CORP /DE/'s 13F Pro composite quality score has ranged between 23 and 54 since 2021, currently 51.4 — an improving long-term trajectory across 28 quarterly and live scoring snapshots.

Fun facts about KEWAUNEE SCIENTIFIC CORP /DE/

Quirks, history, and lore behind KEQU — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. manufacturing company · listed on Nasdaq · headquartered in North Carolina · operates in the laboratory furniture and equipment niche.
  • 2
    The Numbers
    A micro-cap with annual revenue in the range of roughly $200 million — small but remarkably specialized, serving clients who need things that don't tip over when chemicals spill.
  • 3
    The History
    Founded in the late 19th century, it has been outfitting science labs for well over a hundred years — long before 'lab chic' was an interior design trend.
  • 4
    The Secret
    Its customers aren't consumers — they're universities, government agencies, and pharmaceutical companies that need fume hoods, casework, and workbenches built to exacting standards.
  • 5
    The Lore
    The company is incorporated in Delaware but its soul lives in Statesville, NC, where it has manufactured rugged steel and wood lab furniture for generations of scientists.
  • 6
    The Giveaway
    If a high school chemistry lab or a university research facility has solid, no-nonsense benches and cabinets, there's a good chance the name on the order was Kewaunee — named after a Wisconsin town where it all began.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q4 2026

$71.4M

Net Income

Q4 2026

$3.4M

Free Cash Flow

Q4 2026

$4.5M

Operating Margin

Q4 2026

7.3%

ROIC

Q4 2026

5.5%

D/E Ratio

Q4 2026

0.34

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+28.5% YoY
$282.0MFY 2026
FY21 $147.5MFY22 $168.9MFY23 $219.5MFY26 $282.0M

Net Income

+1203.3% YoY
$9.6MFY 2026
FY21 $-3.7MFY22 $-6.1MFY23 $738.0KFY26 $9.6M

Operating Income

+211.6% YoY
$16.7MFY 2026
FY21 $-1.3MFY22 $-2.6MFY23 $5.4MFY26 $16.7M

EPS (Diluted)

+1188.0% YoY
$3.22FY 2026
FY21 $-1.33FY22 $-2.20FY23 $0.25FY26 $3.22

Total Assets

+50.0% YoY
$178.3MFY 2026
FY21 $89.4MFY22 $118.8MFY23 $118.9MFY26 $178.3M

Total Debt

+601.3% YoY
$25.2MFY 2026
FY21 $6.8MFY22 $1.6MFY23 $3.6MFY26 $25.2M

Op. Cash Flow

+591.6% YoY
$18.6MFY 2026
FY21 $912.0KFY22 $-7.9MFY23 $-3.8MFY26 $18.6M

AI Insight: KEQU Financial Trends

Revenue stabilized near $70M after post-acquisition spike, but operating margins remain compressed and cash generation is lumpy.

Operating margin fell from 8.3% in Q2 2025 to 7.0% in Q2 2026, indicating persistent margin pressure despite revenue stability.

Total debt declined from $42M in Q2 2025 to $25M in Q2 2026, reducing leverage and improving balance sheet strength.

Operating cash flow swung from +$9M in Q2 2025 to +$5M in Q2 2026, reflecting inconsistent working capital management.

Revenue declined 8% from Q2 2025 peak ($77M) to Q2 2026 ($71M); sustaining current level critical given margin sensitivity.

Net income remains volatile and low (≤$5M quarterly); operating leverage not yet materializing post-acquisition integration.

Operating cash flow unpredictability (swings from -$4M to +$12M) masks underlying operational efficiency gains from deleveraging.

AI Insight: KEQU Ratio Trends

Kewaunee swung from Q1 2026 collapse (NPM 1.0%, ROE 3.9%) to Q2 2026 recovery (NPM 4.8%, ROE 18.1%), but profitability remains below pre-2025 peaks.

Operating margin rebounded to 7.3% in Q2 2026 from 3.7% in Q1 2026, yet trails Q2 2025's 11.0% and Q4 2024's 9.3%.

Leverage improved; D/E fell to 0.34 in Q2 2026 from 0.67 in Q1 2025, lowest in the series.

ROIC recovered to 20.9% in Q2 2026 from 10.7% in Q1 2026, but below Q2 2025's 32.0% peak.

Q1 2026 profitability crater (NPM 1.0%, ROE 3.9%, ROA 1.6%) signals seasonal or operational stress; sustainability unclear.

Volatility persists: OpMargin ranges 3.4–11.0% over last four quarters; no stable trend established.

Get alerted when KEQU's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for KEWAUNEE SCIENTIFIC CORP /DE/ including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put KEQU on your watchlist

Track score changes the day KEWAUNEE SCIENTIFIC CORP /DE/ files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is KEQU a good stock to buy?

13F Pro's AI-powered analysis of KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for KEQU are available on the KEQU stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own KEQU?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling KEQU. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of KEWAUNEE SCIENTIFIC CORP /DE/'s investment landscape.